Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States
{{output}}
Since its inception in 2002, Model for End-Stage Liver Disease (MELD)-based allocation has undergone a series of revisions, especially with respect to exception points. Hepatocellular carcinoma (HCC) is the most common indication for MELD exceptions, and as a ... ...
